KEGG   DRUG: Nonacog alfaHelp
Entry
D05201                      Drug                                   

Name
Nonacog alfa (USAN/INN);
Nonacog alfa (genetical recombination) (JAN);
Benefix (TN)
Class
Cardiovascular agent
 DG02016  Hemostatics
  DG02013  Blood coagulation factor
  DG02014  Blood coagulation accelerant
   DG02013  Blood coagulation factor
Remark
Therapeutic category: 6343
ATC code: B02BD04
Chemical structure group: DG00171
Product (DG00171): D08797<JP/US> D08794<JP> D05201<JP> D10538<JP> D10757<JP> D10770<JP>
Efficacy
Bleeding suppressant, Replenisher (coagulation factor)
Comment
recombinant factor IX (F9) [HSA:2158] [KO:K01321]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD04 Coagulation factor IX
      D05201  Nonacog alfa (USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6343  Plasma preparations
     D05201  Nonacog alfa (USAN/INN); Nonacog alfa (genetical recombination) (JAN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D05201
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D05201
BRITE hierarchy
Other DBs
CAS: 181054-95-5 113478-33-4
PubChem: 47206920
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system